Relypsa Announces Results From Veltassa Drug-Drug Interaction Studies in Healthy Volunteers
25. Januar 2016 16:05 ET
|
Relypsa, Inc.
Relypsa reports results from Phase 1 in vivo studies in healthy volunteers evaluating potential drug-drug interactions between Veltassa and 12 drugs administered either at the same time or...
Relypsa Announces New Employment Inducement Grants
19. Januar 2016 16:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on January 15, 2016, the compensation committee of the...
Relypsa Announces New Employment Inducement Grants
05. Januar 2016 16:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on January 4, 2016, the compensation committee of the...
Relypsa Announces Veltassa™ is Now Available in the United States for the Treatment of Hyperkalemia
21. Dezember 2015 08:30 ET
|
Relypsa, Inc.
Veltassa is the first FDA-approved medicine for hyperkalemia in more than 50 years Veltassa will be distributed to patients via two nationally-recognized specialty pharmaciesHospitals will receive...
Relypsa Announces New Employment Inducement Grants
17. Dezember 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Dec. 17, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on December 15, 2015, the compensation committee of the...
Relypsa Announces New Employment Inducement Grants
07. Dezember 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on December 1, 2015, the compensation committee of the...
Relypsa to Present at Oppenheimer 26th Annual Healthcare Conference
01. Dezember 2015 16:15 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) today announced that John A. Orwin, president and chief executive officer, will present at the Oppenheimer 26th...
Relypsa Announces New Employment Inducement Grants
19. November 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on November 16, 2015, the compensation committee of the...
Relypsa Announces Results of Sub-Group Analyses from Phase 3 OPAL-HK Trial of Veltassa (patiromer) Presented at ASN Kidney Week 2015
06. November 2015 08:30 ET
|
Relypsa, Inc.
Veltassa significantly reduced and maintained control of blood potassium levels in OPAL-HK pre-specified sub-group analysis of patients age 65 and older with chronic kidney disease (CKD) and...
Relypsa Announces New Employment Inducement Grants
05. November 2015 08:30 ET
|
Relypsa, Inc.
REDWOOD CITY, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on November 2, 2015, the compensation committee of the...